Affiliation:
1. Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico
2. Departments of Pathology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico
Abstract
Lupus nephritis remains an important problem in patients with systemic lupus erythematosus (SLE). Some patients with diffuse proliferative lupus nephritis (DPLN) develop chronic renal failure (CRF). A case-control study was designed to determine the variables associated with CRF in patients with DPLN. We studied 121 patients with biopsy-proven DPLN seen in our institution from 1970 to 1988. There were 34 patients who developed CRF, the remaining were their controls. Clinical charts were reviewed and a pathologist re-scored blindly both activity and chronicity indices. The mean of age at SLE onset was 24.1 ± 7.9 years; the mean disease duration was 9.2 ± 6.1 years for controls and 6.1 ± 5 years for patients. The main variables associated with CRF were male sex, HR (hazard ratio): 12.6 (95% CI 1.6-98.2); activity index, HR 2.59 (1.07-6.3) ; severe infections, HR 2.9 (1.2-7.3); number of antihypertensive drugs, HR 2.5 (1.4-4.7); cellular crescents, HR 1.6 (1.2-2); and interstitial inflammation, HR 2.7 (1.5-5.1). A protective effect was observed with longer use of ≤20 mg of prednisone, HR 0.53 (95% CI 0.34-0.8); azathioprine, HR 0.6 (0.4-0.8); and length of formal education, HR 0.3 (0.09-0.94). Our results indicate that maleness, activity index, extracapillary proliferation and interstitial inflammation, as well as hypertension and severe infections associate with CRF in patients with DPLN, and treatment and higher education, perhaps through better therapeutic compliance, may be protective.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献